Aug. 13, 2020: HCV testing rates among people newly diagnosed with HIV; HCV treatment referrals ammong coinfected people; HIV mortality rates despite free treatment access; mysterious, plummeting CD4 test results.
July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.
A revolution in organ transplants is taking place.
Retire? No, Thanks! This Doc Instead Moved to West Virginia to Fight HIV, Hepatitis C, and the Opioid Crisis
In a poor and conservative state, Judith Feinberg, M.D., aims to expand harm reduction—and bring treatment to active drug users.
Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.
"We're already triaging people," said Kara Vassily, RN, "so for us, this is another series of things we can do to get the rapid HIV and hepatitis C screening done."
Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.
On Jan. 9, the U.S. Food and Drug Administration (FDA) approved a three-in-one test that detects HIV, hepatitis C and hepatitis B.
Improving the utilization of viral hepatitis testing and management was the subject of two oral abstract sessions at the 3rd International Conference on Viral Hepatitis (ICVH 2013), which took place in late March in New York City.
Mark Iscoe (from J...
David Wohl, M.D., takes an in-depth look at this year's most critical HIV-related studies, and explains how each one may change how we prevent and treat HIV in 2012 and beyond. (Fair warning: This article can get pretty technical, but each story has ...